PARK7 (Parkinsonism Associated Degeneration 7), located on chromosome 1p36.23, encodes the protein DJ-1, a highly conserved multifunctional protein involved in oxidative stress response, mitochondrial function, and neuronal survival. Pathogenic variants in PARK7 cause autosomal recessive early-onset Parkinson's disease, and DJ-1 has been implicated in multiple neurodegenerative processes. DJ-1 was originally discovered as an oncogene (DJ-1/PARK7) and later as a protein that protects neurons from oxidative stress.
The PARK7 gene encodes DJ-1 protein, a 189-amino acid protein with multiple functions:
- Oxidative stress response: Scavenges reactive oxygen species (ROS); cysteine residues (Cys106) are critical for oxidative stress sensing
- Mitochondrial function: Maintains mitochondrial complex I activity; translocates to mitochondria under stress
- Transcriptional regulation: Interacts with transcription factors including p53, Nrf2, SOX9, and estrogen receptors
- Protein quality control: Acts as a molecular chaperone; prevents protein aggregation
- Apoptosis inhibition: Blocks both intrinsic and extrinsic apoptotic pathways
- Autophagy regulation: Promotes mitophagy and general autophagy
- ER stress response: Modulates unfolded protein response signaling
DJ-1 forms homodimers and can be secreted, potentially allowing cell-to-cell signaling. It localizes to cytoplasm, nucleus, and mitochondria.
| Feature |
Details |
| Molecular weight |
~20 kDa |
| Structure |
Thiol-specific peroxidase-like fold; dimeric |
| Critical residues |
Cys106 (oxidation sensor), Cys53, Cys57 |
| Post-translation |
Oxidation, phosphorylation, sumoylation |
| Crystal structure |
PDB: 1P5O, 1PVH |
- Inheritance: Autosomal recessive; biallelic loss-of-function variants
- Onset: Early-onset (typically before age 40)
- Phenotype: Typical PD phenotype with good levodopa response
- Neuropathology: Loss of dopaminergic neurons in substantia nigra pars compacta
- D149A: Destabilizes dimer formation; pathogenic
- E64D: Common variant; possible risk modifier
- L166P: Severe loss of function; early onset
- Amyotrophic lateral sclerosis: Some variants may increase risk
- Multiple system atrophy: Under investigation
- Cancer: DJ-1 overexpression in various cancers (oncogenic properties)
- Male infertility: DJ-1 in sperm function
- Brain: Widely expressed; high in substantia nigra, hippocampus, cortex
- Cell types: Neurons, astrocytes, microglia
- Subcellular: Cytoplasm (60%), nucleus (20%), mitochondria (20%)
- Regulation: Nrf2 regulates PARK7 expression under oxidative stress
- Allen Brain Atlas: High expression in dopaminergic neurons
- Bonifati et al., DJ-1 mutations in early-onset Parkinsonism (2003)
- Kahle et al., DJ-1 and Parkinson disease (2009)
- Xie et al., DJ-1 as a redox sensor (2012)
- Jin et al., Mitochondrial dysfunction in PARK7 deficiency (2016)
- Gao et al., DJ-1 in autophagy and mitophagy (2018)
- Repici et al., DJ-1 as therapeutic target (2019)
- Zhang et al., Nrf2 activation by DJ-1 (2020)
- Biosa et al., PARK7 mouse models (2022)
- DJ-1 activators: Enhance DJ-1 function and stability
- Antioxidants: N-acetylcysteine, glutathione precursors
- Nrf2 activators: Promote antioxidant response
¶ Gene Therapy and Protein Delivery
- AAV-PARK7 delivery in preclinical models
- Recombinant DJ-1 protein delivery research
- Mitochondrial protection
- Antioxidant pathway enhancement
- Autophagy modulation
- Protein aggregation prevention